Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-02

Clinical Trial Update: FS2 Safety and Tolerability Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of FS2 in healthy volunteers has been completed; the trial was conducted by the British Columbia Professional Firefighters…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FS2

Snippet

Sponsor: British Columbia Professional Firefighters' Burn and Wound Healing Laboratory | Conditions: Cicatrix, Cicatrix, Hypertrophic | Phase 1 | Status: COMPLETED